Our company news

Smooth Drug Development October 2023 News Release

Published on Sunday November 05, 2023

October We are working on the following new projects: • We signed a contract for medical writing activities for a phase III trial with glucosamine + chondroitin sulfate.

Read more →

Smooth Drug Development September 2023 News Release

Published on Thursday October 05, 2023

We are working on the following new projects: • We signed a contract for medical writing activities for a BE trial with our long-term Client.

Read more →

Smooth Drug Development August 2023 News Release

Published on Tuesday September 05, 2023

August We are working on the following new projects: • We were awarded with medical writing activities for bioequivalence trials with Triptorelin.

Read more →

Smooth Drug Development July 2023 News Release

Published on Saturday August 05, 2023

We are working on the following new projects: • We were awarded with 6 bioequivalence trials with Gliclazide, Liraglutide, Vildagliptin, Dolutegravir and Empagliflozin 10 mg and 25 mg.

Read more →

Smooth Drug Development June 2023 News Release

Published on Wednesday July 05, 2023

We are working on the following new projects: • We signed a contract for a bioequivalence trial with Edoxaban.

Read more →

Smooth Drug Development May 2023 News Release

Published on Monday June 05, 2023

We are working on the following new projects: • We signed 2 contracts for bioequivalence trials with Rivaraxoban.

Read more →

Happy Clinical Trials Day!

Published on Saturday May 20, 2023

His report thus illustrates his awareness of the need to guard against selection bias and shows how he attempted to hold constant potential confounding factors - clinical condition, environment, and basic diet

Read more →

Smooth Drug Development April 2023 News Release

Published on Friday May 05, 2023

April We are working on the following new projects: • We have been awarded several bioequivalence studies

Read more →

Smooth Drug Development March 2023 News Release

Published on Wednesday April 05, 2023

We were awarded with several bioequivalence trials for full services activities (Umifenovir, Tadalafil, Ipidacrine, Sertraline, Silodosine).

Read more →

Seminar on European Pharma & Medical Device Regulation and Overseas Clinical Trial Strategies

Published on Thursday March 30, 2023

Smooth together with Chinese colleagues hosts a seminar on European Pharma & Medical Device Regulation and Overseas Clinical Trial Strategies on 3 April. Feel free to join.

Read more →

Smooth Drug Development February 2023 News Release

Published on Monday March 06, 2023

We were awarded with projects for development of medical documentation and data management.

Read more →

ISO certification in clinical trials

Published on Tuesday February 28, 2023

Compliance with standards is a necessary part of doing business to operate, especially in the field of clinical trials, where the welfare of subjects comes first.

Read more →

Smooth Drug Development January 2023 News Release

Published on Monday February 06, 2023

We are working on the following new projects: • We signed several contracts for medical wring activities for BE trials with different clients.

Read more →

Smooth Drug Development achievements in China

Published on Friday January 27, 2023

Smooth Drug Development achievements in China Smooth Drug Development opened a representative office in China and plans to continue its contribution to the development of therapeutics in China and assist Chinese clients enter EAEU and EC markets

Read more →

Smooth Drug Development December 2022 News Release

Published on Friday January 06, 2023

We are working on the following new projects: • We were awarded with a bioequivalence trial of Ketorolac.

Read more →